Respiratory Research, Inc.

Advances in analytical chemistry have accelerated the pace of exhaled biomarker research. New breath tests and diagnostics are rapidly emerging and changing the medical diagnostic paradigm. Respiratory Research, Inc. develops proprietary medical devices and diagnostics supporting the study of Cystic Fibrosis, Asthma, Lung Cancer and Infectious Disease worldwide. Our RTube™ Exhaled Breath Condensate Collector has been trusted over 230,000 times to capture exhaled biomarkers in academic, pharmaceutical, and government research studies worldwide since 2000. Respiratory Research, Inc. was founded by researchers from the University of Virginia as a means of providing their studies with the tools needed to properly collect and analyze exhaled biomarkers. Since then, the company has relocated to Austin, Texas and become the worldwide standard provider of breath collection and analysis devices with distribution centers in the US, China, UK, Italy, Japan, Australia, Taiwan, India, Brazil, India and South Korea. All our products are designed and manufactured in the USA. Our manufacturing is performed in a ISO-9001 certified clean room facility and meets ISO 13485 and FDA GMP standards to ensure reliable performance and best study results. Breath science is rapidly growing — and we are growing with it. We have added several new products to the RTube family with more in the pipeline to best serve your evolving needs. We always remember where we came from, and our mission continues to be helping the research community advance breath science effectively, safely, and practically. Contact us for the most up-to-date information on new products and emerging research techniques. From product innovation to protocol development to logistical support, we'll help you achieve the best possible study results.

• Employees 4
• Founded 2000
• Annual Revenue $8233000